Skip to main content
OpenTrials

Clinical trial condition

Neurocognitive Disorders

Explore clinical trials studying Neurocognitive Disorders. Study availability and eligibility vary by location and protocol.

7,719 public trials 1,423 recruiting studies
Refine in advanced search Browse all conditions

Neurocognitive Disorders trial results

Recruiting

A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)

NCT06947941

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +9 more
Locations
  • Gilbert Neurology Partners/CCT Research Gilbert, Arizona, United States
  • Inland Psychiatric Medical Group. Chino, California, United States
  • Local Institution - 0001 Naples, Florida, United States
  • Local Institution - 1401 Naples, Florida, United States
View all 22 locations
View Trial Details
Recruiting

Effects of Hydroxytyrosol-Rich Olive Polyphenol Dietary Supplement Combined With Mediterranean Diet Adherence on the Cognitive Health of Patients With Mild Cognitive Impairment

NCT07672938

Conditions
Cognition Disorders, Cognitive Dysfunction, Mental Disorders, +2 more
Locations
  • Palliative Care Centre "Panagia Glykofilousa", Greek Association of Alzheimer's Disease and Related Disorders, Plastira 65, Thessaloniki 54250, Greece. Thessaloniki, Central Macedonia, Greece
View Trial Details
Recruiting

Impact of Personalised Cardiac Anaesthesia and Cerebral Autoregulation on Neurological Outcomes in Patients Undergoing Cardiac Surgery

NCT05595954

Conditions
Cardiovascular Diseases, Cognition Disorders, Cognitive Dysfunction, +18 more
Locations
  • Clinic for Anaesthesia, Intermediate Care, Prehospital Emergency Medicine and Pain Therapy, University Hospital Basel Basel, Switzerland
  • Inselspital, Bern University Hospital Bern, Switzerland
  • Cambridge University Hospitals and Brain Physics Lab Cambridge, United Kingdom
  • Royal Papworth Hospital, Department of Anaesthesia and Intensive Care Cambridge, United Kingdom
View Trial Details
Recruiting

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer's Disease (eAD)

NCT07234942

Conditions
Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations
  • Montreal Neurological Institute Clinical Research Unit Montreal, Quebec, Canada
  • Brain Research Center Amsterdam Amsterdam, North Holland, Netherlands
  • Hospital de la Santa Creu i Sant Pau Barcelona, Spain
  • Hospital Universitario Reina Sofia Córdoba, Spain
View Trial Details
Recruiting

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

NCT06563895

Conditions
Alzheimer Disease, Amyloid Cardiomyopathy, Amyloid Neuropathies, +26 more
Locations
  • University of California, San Diego (UCSD) - Medical Center La Jolla, California, United States
  • University of California, Los Angeles (UCLA) - David Geffen School of Medicine Los Angeles, California, United States
  • University of California, San Francisco (UCSF) San Francisco, California, United States
  • Stanford University Stanford, California, United States
View all 103 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RG6496 in Huntington's Disease

NCT07246941

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations
  • Hospital Britanico de Buenos Aires Ciudad Autonoma Bs As, Argentina
  • Westmead Hospital Westmead, New South Wales, Australia
  • Monash Health Clayton, Victoria, Australia
  • Royal Melbourne Hospital Parkville, Victoria, Australia
View Trial Details

Related conditions